Synmosa Biopharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	16,064	16,248	14,499	14,706	16,021	7,016
Market Cap Growth	12.76%	12.06%	-1.41%	-8.21%	128.36%	2.96%
Enterprise Value	16,981	18,148	16,554	17,100	19,459	10,892
Last Close Price	31.95	32.40	30.68	30.79	34.75	15.05
PE Ratio	19.25	19.77	21.18	24.72	20.05	23.09
Forward PE	-	28.41	28.41	28.41	28.41	28.41
PS Ratio	2.60	2.63	2.61	2.86	3.65	2.17
PB Ratio	1.59	1.61	1.73	1.82	2.41	1.15
P/TBV Ratio	1.93	1.95	2.16	2.39	3.38	1.67
P/FCF Ratio	102.88	104.06	25.61	48.24	31.98	19.39
P/OCF Ratio	39.03	39.48	18.57	28.73	25.42	15.42
EV/Sales Ratio	2.74	2.93	2.98	3.33	4.44	3.37
EV/EBITDA Ratio	15.61	16.70	15.75	18.43	25.58	22.83
EV/EBIT Ratio	22.58	23.31	22.34	27.72	42.24	58.33
EV/FCF Ratio	108.76	116.23	29.24	56.09	38.84	30.10
Debt / Equity Ratio	0.25	0.25	0.30	0.30	0.51	0.57
Debt / EBITDA Ratio	2.26	2.26	2.37	2.56	4.32	7.15
Debt / FCF Ratio	16.10	16.10	4.50	7.98	6.70	9.57
Net Debt / Equity Ratio	-0.04	-0.04	0.08	0.10	0.29	0.41
Net Debt / EBITDA Ratio	-0.38	-0.38	0.63	0.84	2.55	5.19
Net Debt / FCF Ratio	-2.68	-2.68	1.18	2.57	3.87	6.84
Asset Turnover	0.47	0.47	0.46	0.45	0.41	0.31
Inventory Turnover	1.74	1.74	1.83	1.99	1.97	1.59
Quick Ratio	1.93	1.93	1.54	1.35	1.10	0.95
Current Ratio	2.95	2.95	2.42	2.14	1.73	1.64
Return on Equity (ROE)	6.69%	6.69%	5.68%	5.49%	9.71%	1.93%
Return on Assets (ROA)	3.70%	3.70%	3.85%	3.36%	2.68%	1.13%
Return on Invested Capital (ROIC)	5.95%	6.42%	5.87%	4.76%	4.58%	1.61%
Return on Capital Employed (ROCE)	6.60%	6.60%	7.20%	6.40%	5.20%	2.20%
Earnings Yield	5.12%	5.06%	4.72%	4.04%	4.99%	4.33%
FCF Yield	0.97%	0.96%	3.91%	2.07%	3.13%	5.16%
Dividend Yield	1.71%	-	1.96%	1.61%	1.31%	2.31%
Payout Ratio	33.17%	33.17%	33.41%	32.69%	18.60%	26.32%
Buyback Yield / Dilution	-7.00%	-7.00%	-3.49%	-3.84%	0.79%	-2.35%
Total Shareholder Return	-5.29%	-7.00%	-1.53%	-2.22%	2.10%	-0.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.